Partnering with CDMOs can help bridge the innovation gap.
Paul Nelles
Advertisement
Vice President, Vetter Development Service, Vetter Pharma-Fertigung GmbH & Co. KG
Articles by Paul Nelles
Biotechnology projects are complex and subject to many levels of risk during the early clinical phases. What are the secrets to winning at the drug development game?
Advertisement
Latest Updated Articles
Playing the Drug Development GamePublished: December 19th 2011 | Updated:
Strategic Outsourcing in Clinical DevelopmentPublished: December 16th 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
